302 participants
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-28
- Start Date:
- 2025-12-31
- Completion:
- 2026-12-30
Conditions
- HR+/HER2- Breast Cancer
Interventions
- RADIATION
- DRUG
No Results Yet